Transcutaneous monitoring (TCM) is a non-invasive method for patients who need continuous monitoring of oxygen and carbon dioxide with minimal blood draws. Radiometer provides a complete range of transcutaneous monitoring systems, which cover parameters such as tcpO2, tcpCO2 as well as Masimo SET® SpO2 and pulse rate.

Market Analysis and Insights: Global Percutaneous Monitor Device Market
The global Percutaneous Monitor Device market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Percutaneous Monitor Device Scope and Market Size
The global Percutaneous Monitor Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Percutaneous Monitor Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Wound-healing Monitor
Baby Monitor
Other

Segment by Application
Specialty clinics
Diagnostic centers
Adult and pediatric intensive care units
Hospitals
Ambulatory surgical centers
Other

The Percutaneous Monitor Device market is analysed and market size information is provided by regions (countries). Segment by Application, the Percutaneous Monitor Device market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Radiometer Medical
Perimed AB
Philips
Sentec
Medicap
Humares